Rhumbline Advisers Has $423,000 Stake in Liberty Braves Group Series A (NASDAQ:BATRA)

Share on StockTwits

Rhumbline Advisers reduced its position in Liberty Braves Group Series A (NASDAQ:BATRA) by 2.5% during the 1st quarter, HoldingsChannel reports. The fund owned 15,156 shares of the financial services provider’s stock after selling 388 shares during the quarter. Rhumbline Advisers’ holdings in Liberty Braves Group Series A were worth $423,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Loeb Partners Corp acquired a new stake in Liberty Braves Group Series A in the fourth quarter valued at approximately $59,000. BNP Paribas Arbitrage SA lifted its stake in shares of Liberty Braves Group Series A by 3,581.0% in the first quarter. BNP Paribas Arbitrage SA now owns 2,135 shares of the financial services provider’s stock worth $60,000 after buying an additional 2,077 shares during the last quarter. Metropolitan Life Insurance Co. NY lifted its stake in shares of Liberty Braves Group Series A by 353.8% in the fourth quarter. Metropolitan Life Insurance Co. NY now owns 3,594 shares of the financial services provider’s stock worth $90,000 after buying an additional 2,802 shares during the last quarter. Bank of America Corp DE lifted its stake in shares of Liberty Braves Group Series A by 86.6% in the fourth quarter. Bank of America Corp DE now owns 6,560 shares of the financial services provider’s stock worth $164,000 after buying an additional 3,044 shares during the last quarter. Finally, Selz Capital LLC acquired a new stake in shares of Liberty Braves Group Series A in the first quarter worth $201,000. 72.51% of the stock is currently owned by institutional investors and hedge funds.

A number of brokerages have recently weighed in on BATRA. ValuEngine cut shares of Liberty Braves Group Series A from a “buy” rating to a “hold” rating in a research note on Wednesday, April 3rd. TheStreet upgraded shares of Liberty Braves Group Series A from a “d+” rating to a “c” rating in a research note on Tuesday, April 16th.

Shares of Liberty Braves Group Series A stock opened at $26.72 on Thursday. Liberty Braves Group Series A has a 1-year low of $23.54 and a 1-year high of $29.66.

Liberty Braves Group Series A (NASDAQ:BATRA) last issued its quarterly earnings data on Thursday, May 9th. The financial services provider reported ($1.39) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.85) by ($0.54). The firm had revenue of $22.00 million for the quarter.

ILLEGAL ACTIVITY NOTICE: “Rhumbline Advisers Has $423,000 Stake in Liberty Braves Group Series A (NASDAQ:BATRA)” was first published by Ticker Report and is owned by of Ticker Report. If you are reading this piece on another site, it was stolen and reposted in violation of international copyright legislation. The legal version of this piece can be viewed at https://www.tickerreport.com/banking-finance/4370121/rhumbline-advisers-has-423000-stake-in-liberty-braves-group-series-a-nasdaqbatra.html.

About Liberty Braves Group Series A

The Liberty Braves Group, through its subsidiary, Braves Holdings, LLC, owns the Atlanta Braves Major League Baseball Club, stadium, and mixed use development project. The company is based in Englewood, Colorado. The Liberty Braves Group is a subsidiary of Liberty Media Corporation.

Read More: Understanding Options Trading

Want to see what other hedge funds are holding BATRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Liberty Braves Group Series A (NASDAQ:BATRA).

Institutional Ownership by Quarter for Liberty Braves Group Series A (NASDAQ:BATRA)

Receive News & Ratings for Liberty Braves Group Series A Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Braves Group Series A and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Bank of Nova Scotia  Given Consensus Recommendation of “Hold” by Analysts
Bank of Nova Scotia Given Consensus Recommendation of “Hold” by Analysts
Analysts Set Guidewire Software Inc  Price Target at $108.78
Analysts Set Guidewire Software Inc Price Target at $108.78
-$0.13 EPS Expected for Seelos Therapeutics Inc  This Quarter
-$0.13 EPS Expected for Seelos Therapeutics Inc This Quarter
Sun Communities Inc  Receives Consensus Rating of “Hold” from Analysts
Sun Communities Inc Receives Consensus Rating of “Hold” from Analysts
Analysts Set Veracyte Inc  Price Target at $16.83
Analysts Set Veracyte Inc Price Target at $16.83
Zacks: Brokerages Anticipate Unity Biotechnology Inc  Will Announce Earnings of -$0.44 Per Share
Zacks: Brokerages Anticipate Unity Biotechnology Inc Will Announce Earnings of -$0.44 Per Share


© 2006-2019 Ticker Report